Nu102 - Pharmacology Final

Front 1

Monitoring of pertinent baseline hematologic labs is required

Back 1

DDAVP

Front 2

Infusion may hav to be slowed down or discontinued if client develops increased allergic symptoms

Back 2

DDAVP

Front 3

Refer client to support groups for assistance and strengthening of coping mechanisms

Back 3

DDAVP

Front 4

Since client is at risk for bleeding because of factor deficiencies, review concepts of safety as related to lifestyle and job/employment

Back 4

DDAVP

Front 5

Used to treat von Willebrand's disease

Back 5

DDAVP

Front 6

Decrease effects of sympathetic nervous system by blocking action of circulating catecholamines (epinephrine and norepinephrine)

Back 6

Beta Blockers

Front 7

In higher doses, thay may block beta-adrenergic receptors in the airways leading to increased airway resistance especially in clients with asthma or COPD

Back 7

Beta blockers

Front 8

These meds should be administered to all clients with suspected MI and unstable angina in the absence of complications such as COPD

Back 8

Beta blockers

Front 9

They also help prevent v. fib.

Back 9

Beta blockers

Front 10

Monitor BP, HR, and cardiac rhythm frequently during initial administration; if given orally, assess client 30 min before and 60 min after initial dose

Back 10

Beta blockers

Front 11

Give medication at consistent times with or without meals; it is recommended to take the med before meals and at bedtime

Back 11

Beta blockers

Front 12

Side effects: Bradycardia and hypotension

Back 12

Beta Blockers

Front 13

side effects: bronchospasm

Back 13

Beta Blockers

Front 14

side effects: impotence

Back 14

Beta Blockers

Front 15

side effects: weight gain or worsening CHF

Back 15

Beta blockers

Front 16

side effect: dizziness

Back 16

Beta blockers

Front 17

side effect: GI upset

Back 17

Beta blockers

Front 18

Take apical pulse and BP before admin; evaluate client for fluid volume overload as it may indicate CHF

Back 18

Beta blockers

Front 19

Withhold med if HR <60 bpm or if systolic <90 mm Hg

Back 19

Beta blockers

Front 20

Perform head to toe physical exam and assess client thoroughly for a history of asthma, allergies, or COPD

Back 20

Beta blockers

Front 21

The most common adverse reaction is BRADYCARDIA; clients with digitalis toxicity and WPW syndrome are most at risk

Back 21

Beta blockers

Front 22

Abrupt med withdrawal can lead to severe paradoxical or rebound reactions including sweating, tremulousness, severe headache, malaise, palpitations, hypertension, MI and life-threatening heart rhythm disturbances.

Back 22

Beta blockers

Front 23

Stop smoking as this might offset the desired outcomes of controlled HR, BP and prevention of angina

Back 23

Beta blockers

Front 24

Masked cardiovascular signs of hypoglycemia in clients with diabetes mellitus

Back 24

propranolol (Inderal)

Front 25

What's the antidote for MAGNESIUM overdose?

Back 25

Calcium Gluconate

Front 26

acetazolamide (Diamox)

Back 26

Carbonic anhydrase inhibitors

Front 27

Contraindications: 2nd & 3rd degree heart blocks

Back 27

Calcium channel blockers

Front 28

side effects: headache

Back 28

Calcium channel blockers

Front 29

side effects: fatigue

Back 29

Calcium channel blockers

Front 30

side effects: peripheral edema

Back 30

Calcium channel blockers

Front 31

Evaluate BP and ECG befroe initiation of treatment and monitor closely during medication adjustment

Back 31

Calcium channel blockers

Front 32

Report gradual weight gain and evidence of edema; may indicate onset of CHF

Back 32

Calcium channel blockers

Front 33

Importnat to take radial pulse before each dose; especially which one???
irregular pulse or one slower than baseline level should be reported

Back 33

Calcium channel blockers
especially VERAPAMIL

Front 34

stop smoking
avoid alcohol

Back 34

Calcium channel blockers

Front 35

treatment for supraventricular tachycardia

Back 35

adenosine (Adenocard)

Front 36

Give by rapid IV bolus (over 1-2 sec) followed by rapid NS flush

Back 36

adenosine (Adenocard)

Front 37

administer directly into vein as proximal to the insertion site as possible; half-life is only 10 seconds

Back 37

adenosine (Adenocard)

Front 38

Must be stored at room temp to avoid crystallization; if crystals appear, dissolve by warming to room temp

Back 38

adenosine (Adenocard)

Front 39

Monitor ECG continuously

Back 39

adenosine (Adenocard)

Front 40

Monitor carefully for bronchospasm esp in clients with asthma

Back 40

adenosine (Adenocard)